Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M180,089Revenue $M57,854Net Margin (%)16.5Z-Score2.8
Enterprise Value $M194,998EPS $3.9Operating Margin %20.0F-Score7
P/E(ttm))18.7Cash Flow Per Share $5.5Pre-tax Margin (%)19.5Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %7.7Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %4.9Current Ratio1.2Lower Leverage y-yY
Price/Cash Flow11.3y-y EBITDA Growth Rate %59.5ROA % (ttm)7.7Higher Current Ratio y-yY
Dividend Yield %3.5Insider Buy (3m)0ROE % (ttm)13.8Less Shares Outstanding y-yN
Payout Ratio %64.3Shares Outstanding M2,421ROI % (ttm)14.9Gross Margin Increase y-yN

Gurus Latest Trades with NVS

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVSLee Ainslie 2013-03-31 Buy 0.49%$63.3 - $71.32
($67.87)
$ 73.128%New holding, 531689 sh.531,689
NVSVanguard Health Care Fund 2013-03-31 Reduce-0.71%$63.3 - $71.32
($67.87)
$ 73.128%Reduce -85.39%726,200
NVSDodge & Cox 2012-12-31 Add0.11%$58.97 - $63.96
($61.79)
$ 73.1218%Add 2.65%48,438,459
NVSDodge & Cox 2012-09-30 Add0.12%$55.24 - $61.51
($58.49)
$ 73.1225%Add 3.23%47,187,759
NVSMario Gabelli 2012-03-31 Reduce$53.31 - $58.33
($52.37)
$ 73.1240%Reduce -37.42%11,740
NVSMichael Price 2012-03-31 Sold Out -1.3%$53.31 - $58.33
($52.37)
$ 73.1240%Sold Out0
NVSJohn Hussman 2012-03-31 Reduce-0.14%$53.31 - $58.33
($52.37)
$ 73.1240%Reduce -22.44%515,000
NVSMichael Price 2011-06-30 Buy 1.29%$54.23 - $64.52
($59.61)
$ 73.1223%New holding, 144969 sh.144,969
NVSVanguard Health Care Fund 2011-06-30 Add0.45%$54.23 - $64.52
($59.61)
$ 73.1223%Add 30.01%4,869,880
NVSMario Gabelli 2011-06-30 Add$54.23 - $64.52
($59.61)
$ 73.1223%Add 65.83%20,215
NVSMario Gabelli 2011-03-31 Reduce$52.75 - $59.24
($56.19)
$ 73.1230%Reduce -95.51%12,190
NVSVanguard Health Care Fund 2010-12-31 Reduce-0.42%$53.41 - $59.77
($57.3)
$ 73.1228%Reduce -21.07%4,869,880
NVSJohn Hussman 2010-12-31 Reduce-0.34%$53.41 - $59.77
($57.3)
$ 73.1228%Reduce -35.87%643,500
NVSMario Gabelli 2010-09-30 Buy 0.07%$47.85 - $58.09
($51.82)
$ 73.1241%New holding, 272290 sh.272,290
NVSMario Gabelli 2010-06-30 Sold Out $43.78 - $53.83
($48.99)
$ 73.1249%Sold Out0
NVSJohn Hussman 2010-03-31 Buy 0.96%$51.91 - $55.52
($54.06)
$ 73.1235%New holding, 1002250 sh.1,002,250
NVSVanguard Health Care Fund 2010-03-31 Reduce-0.49%$51.91 - $55.52
($54.06)
$ 73.1235%Reduce -27.16%6,169,880
NVSJohn Hussman 2009-12-31 Sold Out -0.24%$49.56 - $56.16
($53.34)
$ 73.1237%Sold Out0
NVSTweedy Browne 2009-09-30 Add0.69%$39.22 - $49.41
($45)
$ 73.1262%Add 175.47%396,951
NVSJohn Hussman 2009-09-30 Reduce-0.12%$39.22 - $49.41
($45)
$ 73.1262%Reduce -50%250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVS Lee Ainslie 2013-03-31531,6890.020.49New Buy
NVS Tweedy Browne 2013-03-31301,9340.010.56+0.18%
NVS Jean-Marie Eveillard 2013-03-3113,06000
NVS Mario Gabelli 2013-03-3110,94000.01
NVS Dodge & Cox 2013-03-3147,505,2721.964.2-1.93%
NVS PRIMECAP Management 2013-03-3127,436,7291.132.9-3.42%
NVS John Hussman 2013-03-31416,9000.021.1-13.31%
NVS Vanguard Health Care Fund 2013-03-31726,2000.030.2-85.39%
Premium Most recent portfolio changes are included for Premium Members only!


NVS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVS :

Quarterly/Annual Reports about NVS:

    News about NVS:

    Articles On GuruFocus.com
    Johnson & Johnson (JNJ) - A must own dividend stock May 31 2013 
    20 Mega Caps and Their Dividend Payments and Which to Consider May 17 2013 
    20 Best-Yielding Health Care Stocks - Less Volatile Than the Market Apr 02 2013 
    Dodge & Cox Explain Why They Are Overweight in Pharmaceuticals Dec 13 2012 
    Is Novartis a Good Buy Right Now? Nov 28 2012 
    The Fiscal Cliff and its Impact to your Portfolio Nov 15 2012 
    Tweedy Browne Q3 Letter Nov 01 2012 
    Ken Fisher’s Top Mega-Cap New Purchases in Q3 Oct 18 2012 
    The 20 Biggest Healthcare Dividend Payer Oct 02 2012 
    comment on NVS Sep 30 2012 

    More From Our Partners
    Positive Data on Novartis' Jakavi - Analyst Blog Jun 18 2013 - ZACKS

    Add Notes, Comments or Ask Questions

    Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK